Filter
1324
Filtered Results: 1324
Text search:
co-morbidities
Featured
Recommendations
146
New Publications
236
Language
Document type
No document type
556
Guidelines
302
Studies & Reports
257
Strategic & Response Plan
62
Manuals
60
Fact sheets
45
Situation Updates
15
Training Material
13
Infographics
8
Resource Platforms
4
Brochures
1
Online Courses
1
Countries / Regions
Global
89
India
80
South Africa
42
Kenya
38
Latin America and the Carribbean
38
Western and Central Europe
32
Africa
27
Ethiopia
22
Nigeria
20
Bangladesh
18
Eastern Europe
17
Brazil
17
Uganda
15
Ghana
14
South–East Asia Region
14
Ukraine
12
Rwanda
12
Nepal
11
Philippines
10
Tanzania
10
East and Southern Africa
10
Myanmar / Burma
10
Sierra Leone
9
Syria
9
Malawi
9
Asia
9
Germany
9
West and Central Africa
9
Middle East and North Africa
9
Namibia
9
Zambia
9
Senegal
8
Congo, Democratic Republic of
8
Russia
8
Indonesia
8
Zimbabwe
7
Eswatini/ Swaziland
6
Cameroon
5
Burkina Faso
5
Peru
5
Mozambique
5
Western Pacific Region
5
South Sudan
5
Colombia
4
Chile
4
Eastern Europe and Central Asia
4
United Kingdom
4
Liberia
4
Lesotho
3
Cambodia
3
Vietnam
3
Georgia
3
Angola
3
Pakistan
3
Tajikistan
2
Turkey
2
Benin
2
Togo
2
Laos
2
Guinea
2
Venezuela
2
North America
2
Portugal
2
Bolivia
2
Argentina
2
Egypt
2
Botswana
2
Somalia
2
Ecuador
2
Madagascar
2
North Macedonia
1
Timor Leste/ East Timor
1
Thailand
1
Mexico
1
Gambia
1
Singapore
1
Estonia
1
Afghanistan
1
Burundi
1
USA
1
Haiti
1
Guinea-Bissau
1
Paraguay
1
Gabon
1
Jamaica
1
France
1
Mauritius
1
Spain
1
Algeria
1
Southern Africa
1
Moldova
1
Romania
1
Central African Republic
1
Chad
1
Authors & Publishers
Publication Years
Category
Countries
482
Clinical Guidelines
167
Public Health
97
Women & Child Health
30
Key Resources
13
Capacity Building
10
Pharmacy & Technologies
2
Toolboxes
COVID-19
280
TB
156
HIV
142
Mental Health
123
NCDs
83
Caregiver
36
AMR
30
NTDs
28
Disability
23
Rapid Response
20
Pharmacy
17
Conflict
17
Refugee
14
Planetary Health
10
Health Financing Toolbox
8
Ebola
7
Cholera
6
Global Health Education
6
Natural Hazards
3
Polio
3
Zika
2
Specific Hazards
1
Social Ethics
1
Scientific Brief, 17 June 2020
This report reviews the latest evidence on what works to reduce HIV-related stigma and discrimination through key programmes to reduce stigma and discrimination and increase access to justice in the six settings of focus for the Global Partnership. It includes guidance for national governments and k...
Lancet Glob Health 2020Published OnlineNovember 27, 2020 https://doi.org/10.1016/S2214-109X(20)30449-6
BMJ 2019;365:l1807 doi: 10.1136/bmj.l1807 (Published 8 May 2019)
MOH clinical practice guidelines
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
Comment The Lancet Volume 397, ISSUE 10269, P72-74, January 09, 2021
Published:December 08, 2020DOI:https://doi.org/10.1016/S0140-6736(20)32623-4
Working Document Nov. 2020
The COVAX Supply and Logistics workstream lead by UNICEF, Gavi and WHO have released a working copy of the COVID-19 Vaccination, Country Readiness & Delivery: Supply and Logistics Guidance. Countries might find this Guide useful when developing and strengthening their sup...
nterim guidance, first issued 25 January 2021, updated 15 June 2021, updated 19 November 2021, updated 23 February 2022, updated 18 August 2022
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc...
13 May 2021 The diagram supports health workers by outlining key steps and messages to communicate during a COVID-19 vaccination session.
Manufacturers:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
Efficacy shown in clinical trials in participants who received the full series of vaccine (2 doses) ir...
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w...
This report describes findings from a telephone survey with 1,323 people conducted in February 2021. The survey examined how people respond to public health and social measures (PHSMs) to prevent COVID-19. The sample is representative of households with access to a landline or cell phone, but does n...
based on information as at 28 February 2021
Rapid Policy Brief Series Series 14: COVID-19 and hypertension
22 April 2021
This study looked at structural risk factors to COVID-19 that existed before the outbreak and may have direct and indirect effects on COVID-19 risk across all the 47 counties in Kenya. These factors are COVID-19 exposure and vulnerability and lack of adaptive capacity to COVID-19.
Many African countries were amongst the most rapid to respond to the emerging threat of COVID-19, implementing large-scale interventions at very early stages of their epidemic. As demonstrated in this document using very simple models, this rapid mobilization and timeliness of implementing control m...
